Computational modeling reveals an in-silico multi-epitope Andes virus vaccine candidate with broad population coverage, highlighting potential targets for experimental hantavirus immunization.
Andes virus (ANDV) causes hantavirus cardiopulmonary syndrome and remains an important target for vaccine development. This study presents the computational design and evaluation of an in-silico multi-epitope ANDV vaccine candidate. The analysis integrates class-I and class-II peptide–HLA prediction, reduction of overlapping predictions to non-redundant candidate regions, sequence-conservation analysis, human-proteome sequence comparison, and genotype-based population-coverage modeling. The resulting candidate combines selected T-cell components with secondary B-cell-directed elements and is characterized computationally across these analytical dimensions. The work is intended as an openly accessible research resource for further computational study, teaching, independent scrutiny, and future experimental investigation.
No takes yet. Share an insight, caveat, or question.
Summus Stuprator (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: